The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Differences in survival for advanced-stage colorectal cancer (CRC) patients by lines of therapy received in a U.S. local oncology practice.
Susan H Foltz Boklage
Employment or Leadership Position - Bayer
Charles Kreilick
Employment or Leadership Position - Bayer
Carl V Asche
Consultant or Advisory Role - Bayer
Sally Haislip
No relevant relationships to disclose
James W. Gilmore
No relevant relationships to disclose
Stephen Szabo
Employment or Leadership Position - Georgia Cancer Specialists
Consultant or Advisory Role - Amgen
Todd E. Williamson
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Satish Valluri
Employment or Leadership Position - Bayer
Brian S. Seal
Employment or Leadership Position - Bayer
Stock Ownership - Bayer